RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.84
−1.82%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.40
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$0.39
- Revenue actual
- $350.0K
- Revenue estimate
- $960.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4.0%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $29
- PT range
- $26 – $31
- Analysts
- 6
6 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.39 | -$0.41 | Miss -4.84% | $350.0K |
| May 19, 2026 | -$0.35 | -$0.41 | Miss -17.14% | $3.0M |
| Nov 6, 2025 | -$0.39 | -$0.43 | Miss -10.26% | — |
| Aug 7, 2025 | -$0.49 | -$0.41 | Beat 16.33% | $677.0K |
| Feb 26, 2025 | -$0.57 | -$0.45 | Beat 21.05% | — |
| May 2, 2024 | -$0.70 | -$0.62 | Beat 11.43% | — |
| Feb 22, 2024 | -$0.76 | -$0.67 | Beat 11.84% | — |
| Nov 2, 2023 | -$0.83 | -$0.54 | Beat 34.94% | — |
| May 4, 2023 | -$0.70 | -$0.78 | Miss -11.43% | $226.0K |
| Feb 23, 2023 | -$0.71 | -$0.56 | Beat 21.13% | $253.0K |
| Nov 3, 2022 | -$0.71 | -$0.76 | Miss -7.04% | $344.0K |
| Aug 4, 2022 | -$0.62 | -$0.71 | Miss -14.52% | $365.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026